AI-guided treatment for high-grade ovarian cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial uses artificial intelligence to help doctors choose the best treatment for high-grade serous ovarian cancer. It looks at your tumor samples and medical history to personalize your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with high-grade serous ovarian cancer.
- Your tumor sample from surgery is available and in good condition.
- Your medical records and follow-up information are complete.
- You have not received chemotherapy or radiation before your surgery.
- You do not have any other active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some high-grade ovarian cancers stop responding to standard chemotherapy. It aims to find ways to overcome that resistance, which may help improve treatment outcomes.
This trial tests whether a treatment plan tailored to your specific tumor and health can work better for advanced ovarian, peritoneal, or fallopian tube cancer. It aims to find the best therapy for each patient to improve outcomes.
This trial is testing an artificial intelligence system that helps doctors diagnose ovarian tumors more accurately using imaging and blood tests. It may lead to better treatment decisions for patients.
This trial uses a special imaging technique to study high-grade serous ovarian cancer. It aims to better understand the tumor to improve treatment. If you have advanced ovarian cancer and are scheduled for surgery, you may be eligible.
This study looks at results from surgery to remove as much advanced ovarian cancer as possible after chemotherapy. Participating hospitals are in Italy and Canada.
This study looks at how medical images relate to genetic patterns in high-grade serous ovarian cancer. It may help find better ways to diagnose and treat this specific type of ovarian cancer.
Hear when a new High-grade Serous Ovarian Carcinoma (HGSOC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.